| 1 | [SID24826894] | Active | Potency | 1.5849 | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | Potency | 1.5849 [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 2 | [SID24826894] | Active | Potency | 1.5849 | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | Potency | 1.5849 [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 3 | [SID24826894] | Active | AC50 | 2.24 | FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_Dose_CherryPick_Activity [AID652116, Type: confirmatory] | RAD52 gene product [Homo sapiens] [gi:109637798] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | AC50 | 2.24 [uM] | | BioAssay | FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_Dose_CherryPick_Activity | | AID | 652116 | | BioAssay type | confirmatory | | Target | RAD52 gene product [Homo sapiens] [gi:109637798] | | PubMed | | | Data Table |  |
|
| 4 | [SID24826894] | Active | IC50 | 3.69 | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651968, Type: confirmatory] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | IC50 | 3.69 [uM] | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) | | AID | 651968 | | BioAssay type | confirmatory | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 5 | [SID24826894] | Active | IC50 | 3.69 | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651968, Type: confirmatory] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | IC50 | 3.69 [uM] | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) | | AID | 651968 | | BioAssay type | confirmatory | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 6 | [SID24826894] | Active | IC50 | 3.69 | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651968, Type: confirmatory] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | IC50 | 3.69 [uM] | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) | | AID | 651968 | | BioAssay type | confirmatory | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 7 | [SID24826894] | Active | Potency | 5.0119 | Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504848, Type: confirmatory] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | Potency | 5.0119 [uM] | | BioAssay | Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504848 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID24826894] | Active | IC50 | 7.21 | Dose response confirmation of uHTS RPN11 inhibitor hits in a Fluorescence Polarization assay [AID602368, Type: confirmatory] | PSMD14 protein [Homo sapiens] [gi:16306916] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | IC50 | 7.21 [uM] | | BioAssay | Dose response confirmation of uHTS RPN11 inhibitor hits in a Fluorescence Polarization assay | | AID | 602368 | | BioAssay type | confirmatory | | Target | PSMD14 protein [Homo sapiens] [gi:16306916] | | PubMed | | | Data Table |  |
|
| 9 | [SID24826894] | Active | Potency | 7.9433 | Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504850, Type: confirmatory] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | Potency | 7.9433 [uM] | | BioAssay | Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504850 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID24826894] | Active | IC50 | 8.942 | Luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651970, Type: confirmatory] | NR5A2 gene product [Homo sapiens] [gi:4504343] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | IC50 | 8.942 [uM] | | BioAssay | Luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) | | AID | 651970 | | BioAssay type | confirmatory | | Target | NR5A2 gene product [Homo sapiens] [gi:4504343] | | PubMed | | | Data Table |  |
|
| 11 | [SID24826894] | Active | IC50 | 8.942 | Luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651970, Type: confirmatory] | NR5A2 gene product [Homo sapiens] [gi:4504343] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | IC50 | 8.942 [uM] | | BioAssay | Luminescence-based cell-based high throughput dose response assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) | | AID | 651970 | | BioAssay type | confirmatory | | Target | NR5A2 gene product [Homo sapiens] [gi:4504343] | | PubMed | | | Data Table |  |
|
| 12 | [SID24826894] | Active | IC50 | 9.89 | Dose Response confirmation of uHTS small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay [AID504765, Type: confirmatory] | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase [Plasmodium berghei] [gi:12381848] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | IC50 | 9.89 [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay | | AID | 504765 | | BioAssay type | confirmatory | | Target | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase [Plasmodium berghei] [gi:12381848] | | PubMed | | | Data Table |  |
|
| 13 | [SID24826894] | Active | Potency | 12.5893 | qHTS of Nrf2 Activators [AID624171, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS of Nrf2 Activators | | AID | 624171 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 14 | [SID24826894] | Active | Potency | 12.5893 | qHTS of Nrf2 Activators [AID624171, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS of Nrf2 Activators | | AID | 624171 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 15 | [SID24826894] | Active | Potency | 12.5893 | qHTS of Nrf2 Activators [AID624171, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS of Nrf2 Activators | | AID | 624171 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 16 | [SID24826894] | Active | Potency | 12.5893 | qHTS of Nrf2 Activators [AID624171, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS of Nrf2 Activators | | AID | 624171 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 17 | [SID24826894] | Active | IC50 | 21.2 | Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay [AID602361, Type: confirmatory] | 72 kDa type IV collagenase isoform a preproprotein [Homo sapiens] [gi:11342666] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | IC50 | 21.2 [uM] | | BioAssay | Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay | | AID | 602361 | | BioAssay type | confirmatory | | Target | 72 kDa type IV collagenase isoform a preproprotein [Homo sapiens] [gi:11342666] | | PubMed | | | Data Table |  |
|
| 18 | [SID24826894] | Active | IC50 | 21.2 | Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay [AID602361, Type: confirmatory] | 72 kDa type IV collagenase isoform a preproprotein [Homo sapiens] [gi:11342666] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | IC50 | 21.2 [uM] | | BioAssay | Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay | | AID | 602361 | | BioAssay type | confirmatory | | Target | 72 kDa type IV collagenase isoform a preproprotein [Homo sapiens] [gi:11342666] | | PubMed | | | Data Table |  |
|
| 19 | [SID24826894] | Active | IC50 | 21.2 | Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay [AID602361, Type: confirmatory] | 72 kDa type IV collagenase isoform a preproprotein [Homo sapiens] [gi:11342666] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | IC50 | 21.2 [uM] | | BioAssay | Dose Response validation of uHTS RPN11 inhibitor hits using a MMP-2 Fluorescence assay | | AID | 602361 | | BioAssay type | confirmatory | | Target | 72 kDa type IV collagenase isoform a preproprotein [Homo sapiens] [gi:11342666] | | PubMed | | | Data Table |  |
|
| 20 | [SID24826894] | Active | Potency | 39.8107 | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins [AID485364, Type: confirmatory] | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins | | AID | 485364 | | BioAssay type | confirmatory | | Target | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] | | PubMed | | | Data Table |  |
|
| 21 | [SID24826894] | Active | | | MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators [AID1814, Type: screening] | |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | BioAssay | MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators | | AID | 1814 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 22 | [SID24826894] | Active | | | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651614, Type: screening] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) | | AID | 651614 | | BioAssay type | screening | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 23 | [SID24826894] | Active | | | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651614, Type: screening] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) | | AID | 651614 | | BioAssay type | screening | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 24 | [SID24826894] | Active | | | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651614, Type: screening] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) | | AID | 651614 | | BioAssay type | screening | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 25 | [SID24826894] | Active | | | Luminescence-based cell-based high throughput confirmation assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651613, Type: screening] | NR5A2 gene product [Homo sapiens] [gi:4504343] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) | | AID | 651613 | | BioAssay type | screening | | Target | NR5A2 gene product [Homo sapiens] [gi:4504343] | | PubMed | | | Data Table |  |
|
| 26 | [SID24826894] | Active | | | Luminescence-based cell-based high throughput confirmation assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID651613, Type: screening] | NR5A2 gene product [Homo sapiens] [gi:4504343] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) | | AID | 651613 | | BioAssay type | screening | | Target | NR5A2 gene product [Homo sapiens] [gi:4504343] | | PubMed | | | Data Table |  |
|
| 27 | [SID24826894] | Active | | | uHTS identification of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay [AID504690, Type: screening] | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase [Plasmodium berghei] [gi:12381848] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay | | AID | 504690 | | BioAssay type | screening | | Target | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase [Plasmodium berghei] [gi:12381848] | | PubMed | | | Data Table |  |
|
| 28 | [SID24826894] | Active | | | uHTS identification of inhibitors of Rpn11 in a Fluorescent Polarization assay [AID588493, Type: screening] | PSMD14 protein [Homo sapiens] [gi:16306916] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | BioAssay | uHTS identification of inhibitors of Rpn11 in a Fluorescent Polarization assay | | AID | 588493 | | BioAssay type | screening | | Target | PSMD14 protein [Homo sapiens] [gi:16306916] | | PubMed | | | Data Table |  |
|
| 29 | [SID24826894] | Active | | | Single concentration confirmation of uHTS small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay [AID504753, Type: screening] | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase [Plasmodium berghei] [gi:12381848] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay | | AID | 504753 | | BioAssay type | screening | | Target | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase [Plasmodium berghei] [gi:12381848] | | PubMed | | | Data Table |  |
|
| 30 | [SID24826894] | Active | | | Inhibition of the MLL-AF4-AF9 Interaction in Pediatric Leukemia Measured in Biochemical System Using Plate Reader - 2160-01_Inhibitor_SinglePoint_HTS_Activity [AID651704, Type: screening] | MLLT3 gene product [Homo sapiens] [gi:156104889] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | BioAssay | Inhibition of the MLL-AF4-AF9 Interaction in Pediatric Leukemia Measured in Biochemical System Using Plate Reader - 2160-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 651704 | | BioAssay type | screening | | Target | MLLT3 gene product [Homo sapiens] [gi:156104889] | | PubMed | | | Data Table |  |
|
| 31 | [SID24826894] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). [AID2176, Type: screening] | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). | | AID | 2176 | | BioAssay type | screening | | Target | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] | | PubMed | | | Data Table |  |
|
| 32 | [SID24826894] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). [AID2176, Type: screening] | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). | | AID | 2176 | | BioAssay type | screening | | Target | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] | | PubMed | | | Data Table |  |
|
| 33 | [SID24826894] | Active | | | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). [AID1974, Type: screening] | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | BioAssay | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). | | AID | 1974 | | BioAssay type | screening | | Target | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] | | PubMed | | | Data Table |  |
|
| 34 | [SID24826894] | Active | | | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). [AID1974, Type: screening] | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | BioAssay | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). | | AID | 1974 | | BioAssay type | screening | | Target | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] | | PubMed | | | Data Table |  |
|
| 35 | [SID24826894] | Active | | | uHTS identification of small molecule inhibitors of Csn-mediated Deneddylation of Cullin-Ring Ligases, vis a fluorescence polarization assay [AID651999, Type: screening] | COPS5 gene product [Homo sapiens] [gi:38027923] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of Csn-mediated Deneddylation of Cullin-Ring Ligases, vis a fluorescence polarization assay | | AID | 651999 | | BioAssay type | screening | | Target | COPS5 gene product [Homo sapiens] [gi:38027923] | | PubMed | | | Data Table |  |
|
| 36 | [SID24826894] | Active | | | MLPCN maternal gene expression-MEX-5 TCR-2 binding assay-Primary Screen [AID1832, Type: screening] | Zinc finger protein mex- [gi:55976631] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | BioAssay | MLPCN maternal gene expression-MEX-5 TCR-2 binding assay-Primary Screen | | AID | 1832 | | BioAssay type | screening | | Target | Zinc finger protein mex- [gi:55976631] | | PubMed | | | Data Table |  |
|
| 37 | [SID24826894] | Active | | | MLPCN maternal gene expression-MEX-5 TCR-2 binding assay-Primary Screen [AID1832, Type: screening] | Zinc finger protein mex- [gi:55976631] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | BioAssay | MLPCN maternal gene expression-MEX-5 TCR-2 binding assay-Primary Screen | | AID | 1832 | | BioAssay type | screening | | Target | Zinc finger protein mex- [gi:55976631] | | PubMed | | | Data Table |  |
|
| 38 | [SID24826894] | Active | | | FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_SinglePoint_HTS_Activity_Set2 [AID651710, Type: screening] | RAD52 gene product [Homo sapiens] [gi:109637798] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | BioAssay | FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_SinglePoint_HTS_Activity_Set2 | | AID | 651710 | | BioAssay type | screening | | Target | RAD52 gene product [Homo sapiens] [gi:109637798] | | PubMed | | | Data Table |  |
|
| 39 | [SID24826894] | Active | | | Single concentration confirmation of uHTS inhibitor hits from RPN11 in a Fluorescence Polarization assay [AID602318, Type: screening] | PSMD14 protein [Homo sapiens] [gi:16306916] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS inhibitor hits from RPN11 in a Fluorescence Polarization assay | | AID | 602318 | | BioAssay type | screening | | Target | PSMD14 protein [Homo sapiens] [gi:16306916] | | PubMed | | | Data Table |  |
|
| 40 | [SID24826894] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 41 | [SID24826894] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 42 | [SID24826894] | Inactive | Potency | 0.0032 | qHTS Assay for Enhancers of SMN2 Splice Variant Expression [AID1458, Type: confirmatory] | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Inactive | | Potency | 0.0032 [uM] | | BioAssay | qHTS Assay for Enhancers of SMN2 Splice Variant Expression | | AID | 1458 | | BioAssay type | confirmatory | | Target | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] | | PubMed | | | Data Table |  |
|
| 43 | [SID24826894] | Inactive | Potency | 0.0032 | qHTS Assay for Enhancers of SMN2 Splice Variant Expression [AID1458, Type: confirmatory] | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Inactive | | Potency | 0.0032 [uM] | | BioAssay | qHTS Assay for Enhancers of SMN2 Splice Variant Expression | | AID | 1458 | | BioAssay type | confirmatory | | Target | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] | | PubMed | | | Data Table |  |
|
| 44 | [SID24826894] | Inactive | IC50 | 26.351 | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify nonselective inhibitors of the Steroidogenic acute regulatory protein (StAR) promoter or luminescence assay artifacts [AID651969, Type: confirmatory] | |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Inactive | | IC50 | 26.351 [uM] | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify nonselective inhibitors of the Steroidogenic acute regulatory protein (StAR) promoter or luminescence assay artifacts | | AID | 651969 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 45 | [SID24826894] | Inactive | IC50 | 26.773 | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16) [AID651973, Type: confirmatory] | transactivating tegument protein VP16 [Human herpesvirus 1] [gi:9629429] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Inactive | | IC50 | 26.773 [uM] | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16) | | AID | 651973 | | BioAssay type | confirmatory | | Target | transactivating tegument protein VP16 [Human herpesvirus 1] [gi:9629429] | | PubMed | | | Data Table |  |
|
| 46 | [SID24826894] | Inactive | Potency | 28.1838 | qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy [AID624291, Type: confirmatory] | Glycoprotein hormones alpha chain [gi:121312] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Inactive | | Potency | 28.1838 [uM] | | BioAssay | qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy | | AID | 624291 | | BioAssay type | confirmatory | | Target | Glycoprotein hormones alpha chain [gi:121312] | | PubMed | | | Data Table |  |
|
| 47 | [SID24826894] | Inactive | IC50 | 80 | Human Glucose-6-Phosphate Dehydrogenase Dose Response Selectivity Assay for Inhibitors of Plasmodium falciparum Glucose-6-Phosphate Dehydrogenase [AID504792, Type: confirmatory] | G6PD gene product [Homo sapiens] [gi:108773793] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Inactive | | IC50 | 80 [uM] | | BioAssay | Human Glucose-6-Phosphate Dehydrogenase Dose Response Selectivity Assay for Inhibitors of Plasmodium falciparum Glucose-6-Phosphate Dehydrogenase | | AID | 504792 | | BioAssay type | confirmatory | | Target | G6PD gene product [Homo sapiens] [gi:108773793] | | PubMed | | | Data Table |  |
|
| 48 | [SID24826894] | Inactive | IC50 | 80 | Human Glucose-6-Phosphate Dehydrogenase Dose Response Selectivity Assay for Inhibitors of Plasmodium falciparum Glucose-6-Phosphate Dehydrogenase [AID504792, Type: confirmatory] | G6PD gene product [Homo sapiens] [gi:108773793] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Inactive | | IC50 | 80 [uM] | | BioAssay | Human Glucose-6-Phosphate Dehydrogenase Dose Response Selectivity Assay for Inhibitors of Plasmodium falciparum Glucose-6-Phosphate Dehydrogenase | | AID | 504792 | | BioAssay type | confirmatory | | Target | G6PD gene product [Homo sapiens] [gi:108773793] | | PubMed | | | Data Table |  |
|
| 49 | [SID24826894] | Inactive | IC50 | 80 | Dose Response orthogonal assay utilizing the direct end-point detection of NADPH for uHTS small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase [AID540252, Type: confirmatory] | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase [Plasmodium berghei] [gi:12381848] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Inactive | | IC50 | 80 [uM] | | BioAssay | Dose Response orthogonal assay utilizing the direct end-point detection of NADPH for uHTS small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase | | AID | 540252 | | BioAssay type | confirmatory | | Target | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase [Plasmodium berghei] [gi:12381848] | | PubMed | | | Data Table |  |
|
| 50 | [SID24826894] | Inactive | IC50 | 80 | Dose Response orthogonal kinetic assay utilizing the direct detection of NADPH for uHTS small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase [AID540269, Type: confirmatory] | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase [Plasmodium berghei] [gi:12381848] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 24826894 | | CID | 2434777 | | Outcome | Inactive | | IC50 | 80 [uM] | | BioAssay | Dose Response orthogonal kinetic assay utilizing the direct detection of NADPH for uHTS small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase | | AID | 540269 | | BioAssay type | confirmatory | | Target | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase [Plasmodium berghei] [gi:12381848] | | PubMed | | | Data Table |  |
|